Source: International Congress 2016 – The future of lung function is beginning now
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marina Yu. Kameneva (Saint Petersburg, Russian Federation), Marina Yu Kameneva, Vasiliy Trofimov, Artem Tishkov, Alexandra Speranskaya, Ivetta Dvorakovskaya, Olga Baranova. Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs). Eur Respir J 2016; 48: Suppl. 60, 4407

Member's Comments

No comment yet.

Related content which might interest you: Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Determining why patients with idiopathic pulmonary fibrosis (IPF) have difficulty performing gas transfer Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Changes in pulmonary gas exchange in histiocytosis X patients depending on the type of ventilation disorders Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD) Source: International Congress 2014 – ILDs 5 Year: 2014 Outcomes in interstitial lung diseases (ILDs) Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 1 Year: 2014 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context Year: 2013 A trial of the measurement of dynamic lung compliance by the new method using photoplethysmography in patients with COPD and pulmonary fibrosis Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Interstitial lung disease; where do we stand without histopathology? Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013